Pembrolizumab in Early Triple-Negative Breast Cancer. Reply. Schmid P, Cortes J, Dent R. N Engl J Med 2022;386:1771-1772.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schmid P, Cortes J, Dent R. Pembrolizumab in Early Triple-Negative Breast Cancer. Reply. N Engl J Med 2022;386:1771-1772.
PMID: 35507498